Education Library

Nicoletta D’Ettore, MD, discusses diagnosis and management of patients with fulminant myocarditis and the role of temporary mechanical circulatory support.

Ahmad Mahajna, MD, discusses his paper about current insights on temporary mechanical circulatory support in adults with post-cardiotomy cardiogenic shock.

Professor Christophe Vandenbriele, MD, discusses the role of temporary mechanical circulatory support in acute on chronic heart failure and cardiogenic shock.

Tharusan Thevathasan, MD, discusses his paper about the heart team approach to cardiac arrest.

Jacob Møller, MD, and Chuck Simonton, MD, discuss the DanGer Shock RCT and new data presented at TCT 2024.

Babar Basir, DO, discusses revascularization best practices in patients with cardiogenic shock.

Dr. Babar Basir, DO, discusses the importance of the timing to MCS insertion for outcomes in patients with cardiogenic shock.

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Mir B. Basir, DO, discusses the impact of the DanGer Shock RCT in clinical practice, and looks into the future of AMI cardiogenic shock treatment and management.

The NCSI (National Cardiogenic Shock Initiative) assessed the feasibility of using a shock protocol and in-hospital survival in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS).

Arkadiusz Pietrasik, MD, PhD, and Aleksandra Gąsecka, MD, PhD discuss their recently published findings from the IMPELLA-PL registry in Poland.

Professor Giuseppe Tarantini discusses timing and treatment strategies for cardiogenic shock.

Andrea Montisci, M.D., discusses criteria for planning the appropriate therapeutic approach and predicting outcomes in patients with cardiogenic shock.

Alexander Bernhardt, MD, discusses insertion, escalation, de-escalation, and weaning of MCS devices in patients with cardiogenic shock.

“The decision to escalate, de-escalate or wean is highly dependent on patient presentation, capabilities of the institution, and the expertise of the heart team,” write the authors of this paper on differential usage of Impella devices, extracorporeal membrane oxygenation (ECMO), and combined str